Coronavirus (SARS-CoV-2) Nucleic Acid Dual-Detection BioGenomics™ Kit (Real-Time PCR Method) (Research Use Only)

An unexplained pneumonia epidemic broke out in Wuhan at the end of 2019. On February 11, 2020, the World Health Organization (WHO) has named the virus as SARS-CoV-2 (2019 Novel Coronavirus).||Intended Use (Research Use Only):|This Coronavirus (SARS-CoV-2) Nucleic Acid Dual-Detection BioGenomics™ Kit is used for the clinical qualitative detection of SARS-CoV-2 nucleic acid in specimens such as throat swabs, nasal swabs, the extract of nasopharyngeal, sputum, the extract of the respiratory tract, bronchial perfusate, alveolar lavage fluid, lung tissue, stool, urine, blood or serum.||Test Principle: |The Coronavirus (SARS-CoV-2) Nucleic Acid Dual-Detection BioGenomics™ Kit designs pairs of specific primers and Taqman probes for the conserved regions of the SARS-CoV-2 (2019 Novel Coronavirus) N gene and ORF1ab gene sequence which recently announced on the GISAID. The SARS-CoV-2 nucleic acid in the specimens is qualitatively analyzed by using one-step Real-time PCR detection technology after RNA extraction. The kit uses human-derived ribonuclease P (RNP) as an internal control gene, which can monitor the sample collection and extraction process to avoid false-negative generation to the greatest extent.||Kit Components (25Tests/50Tests):|1. N/ORF1ab RT-PCR Mix, 1vial(425ul)/1vial(850ul)|2. N/ORF1ab primer and probe Mix, 1vial(50ul)/1vial(100ul)|3. N/ORF1ab Enzyme Mix, 1vial(25ul)/1vial(50ul)|4. Negative control, 1vial(30ul)/1vial(30ul)|5. N/ORF1ab positive control, 1vial(30ul)/1vial(30ul)||Storage and Stability:|All the reagents should be stored below -20°C in the dark for no longer than 12 months after receipt. Repeated free-thaw should be avoided.